The oncogenic potential of human cytomegalovirus.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000230:Adenocarcinoma / Q000209:etiology; D000293:Adolescent; D000328:Adult; D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D009189:Avian Myeloblastosis Virus / Q000235:genetics; D001483:Base Sequence; D002472:Cell Transformation, Viral; D003110:Colonic Neoplasms / Q000209:etiology; D003587:Cytomegalovirus / Q000235:genetics / Q000254:growth & development / Q000276:immunology / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000150:complications / Q000151:congenital / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology; D004262:DNA Restriction Enzymes; D004279:DNA, Viral; D005260:Female; D006716:Homosexuality; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007962:Leukocytes / Q000382:microbiology; D008297:Male; D008954:Models, Biological; D009369:Neoplasms / Q000209:etiology*; D011247:Pregnancy; D011471:Prostatic Neoplasms / Q000209:etiology; D012514:Sarcoma, Kaposi / Q000209:etiology; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000209:etiology
D000956:Antigens, Viral; D004279:DNA, Viral; D004262:DNA Restriction Enzymes